{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T20:11:19Z","timestamp":1791403879639,"version":"4.3.3"},"reference-count":42,"publisher":"MDPI AG","issue":"5","license":[{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Taejoon Pharm Inc","award":["none"],"award-info":[{"award-number":["none"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJERPH"],"abstract":"<jats:p>Hyaluronic acid (HA) is commonly used for treating dry eye syndrome (DES). This meta-analysis was performed to compare the efficacies of HA- and non-HA-based eye drops, including saline and conventional artificial tears (ATs), for the treatment of dry eye disease. Eight databases (PubMed, EMBASE, Cochrane Central Register of Controlled Trials, DBpia, KoreaMed, KMBASE, RISS, KISS) were searched for studies comparing the efficacies of HA- and non-HA-based ATs in patients with DES published up to September 2020. Two independent reviewers assessed the quality and extracted the relevant data. The mean differences of Schirmer\u2019s (SH) test scores, tear breakup times (TBUT), corneal fluorescein staining scores (Oxford scale, 0\u20134), and ocular surface disease indexes were calculated. The standard mean difference and 95% confidence interval were calculated using a random effect model. Nineteen studies, including 2078 cases, were included. HA eye drops significantly improved tear production compared with non-HA-based eye drops (standard mean difference (SMD) 0.18; 95% confidence interval (CI) 0.03, 0.33). In a subgroup analysis, the SH test scores and TBUT values after using HA significantly increased compared to those measured after using saline (SMD 0.27; 95% CI 0.05, 0.49 and SMD 0.28; 95% CI 0.03, 0.52, respectively). Based on these results, HA eye drops may be superior to non-HA eye drops including normal saline and ATs. Further research is needed to assess the efficacies stratified by age, treatment duration, the severity of dry eye, and optimal dosages.<\/jats:p>","DOI":"10.3390\/ijerph18052383","type":"journal-article","created":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T10:25:18Z","timestamp":1614594318000},"page":"2383","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":85,"title":["A Meta-Analysis of the Efficacy of Hyaluronic Acid Eye Drops for the Treatment of Dry Eye Syndrome"],"prefix":"10.3390","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5461-1534","authenticated-orcid":false,"given":"Yun-Jung","family":"Yang","sequence":"first","affiliation":[{"name":"Institute of Biomedical Science, Catholic Kwandong University International St. Mary\u2019s Hospital, Incheon 22711, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3062-3973","authenticated-orcid":false,"given":"Won-Young","family":"Lee","sequence":"additional","affiliation":[{"name":"Department of Preventive Medicine, College of Medicine, Chung-Ang University, Seoul 06974, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Young-jin","family":"Kim","sequence":"additional","affiliation":[{"name":"Executive Director of the Korean Contact Lens Study Society, Seoul 07345, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yeon-pyo","family":"Hong","sequence":"additional","affiliation":[{"name":"Department of Preventive Medicine, College of Medicine, Chung-Ang University, Seoul 06974, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2021,3,1]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"DEWS (2007). The definition and classification of dry eye disease: Report of the Definition and Classification Subcommittee of the International Dry Eye WorkShop (2007). Ocul. Surf., 5, 75\u201392.","DOI":"10.1016\/S1542-0124(12)70081-2"},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"International Dry Eye WorkShop Study Group (2007). The epidemiology of dry eye disease: Report of the Epidemiology Subcommittee of the International Dry Eye WorkShop (2007). Ocul. Surf., 5, 93\u2013107.","DOI":"10.1016\/S1542-0124(12)70082-4"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.preteyeres.2004.04.003","article-title":"Changes in the tear film and ocular surface from dry eye syndrome","volume":"23","author":"Johnson","year":"2004","journal-title":"Prog. Retin. Eye Res."},{"key":"ref_4","first-page":"71","article-title":"The pathophysiology, diagnosis, and treatment of dry eye disease","volume":"112","author":"Messmer","year":"2015","journal-title":"Dtsch. Arztebl. Int."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1097\/01.ico.0000611384.81547.8d","article-title":"Current patterns in the use of diagnostic tests in dry eye evaluation","volume":"27","author":"Smith","year":"2008","journal-title":"Cornea"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.jtos.2017.05.006","article-title":"TFOS DEWS II Management and Therapy Report","volume":"15","author":"Jones","year":"2017","journal-title":"Ocul. Surf."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1517\/14656566.2010.518612","article-title":"Pharmacotherapy of dry eye","volume":"12","author":"Dogru","year":"2011","journal-title":"Expert Opin. Pharmacother."},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"DEWS (2007). Management and therapy of dry eye disease: Report of the Management and Therapy Subcommittee of the International Dry Eye WorkShop (2007). Ocul. Surf., 5, 163\u2013178.","DOI":"10.1016\/S1542-0124(12)70085-X"},{"key":"ref_9","first-page":"1075","article-title":"Chemical structure of hyaluronic acid","volume":"17","author":"Meyer","year":"1958","journal-title":"Fed. Proc."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1136\/bjo.79.11.1007","article-title":"Sodium hyaluronate eyedrops in the treatment of dry eyes","volume":"79","author":"Shimmura","year":"1995","journal-title":"Br. J. Ophthalmol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1097\/ICL.0000000000000236","article-title":"Efficacy and Safety of 0.2% Hyaluronic Acid in the Management of Dry Eye Disease","volume":"43","year":"2017","journal-title":"Eye Contact Lens"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.jfo.2011.07.017","article-title":"Efficacy of 0.18% hypotonic sodium hyaluronate ophthalmic solution in the treatment of signs and symptoms of dry eye disease","volume":"35","author":"Baeyens","year":"2012","journal-title":"J. Fr. Ophtalmol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/j.ajo.2009.09.023","article-title":"Demonstration of efficacy in the treatment of dry eye disease with 0.18% sodium hyaluronate ophthalmic solution (vismed, rejena)","volume":"149","author":"Vogel","year":"2010","journal-title":"Am. J. Ophthalmol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1097\/ICO.0b013e318180e55c","article-title":"Effect of hypotonic 0.4% hyaluronic acid drops in dry eye patients: A cross-over study","volume":"27","author":"Troiano","year":"2008","journal-title":"Cornea"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1089\/jop.2018.0032","article-title":"Comparison of 0.1%, 0.18% and 0.3% Hyaluronic Acid Eye Drops in the Treatment of Experimental Dry Eye","volume":"34","author":"You","year":"2018","journal-title":"J. Ocul. Pharmacol. Ther."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1097\/ICO.0b013e3181b11648","article-title":"Comparative analysis of carmellose 0.5% versus hyaluronate 0.15% in dry eye: A flow cytometric study","volume":"29","author":"Sanchez","year":"2010","journal-title":"Cornea"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1097\/ICO.0000000000001523","article-title":"Effects of Lipid-Versus Sodium Hyaluronate-Containing Eye Drops on Optical Quality and Ocular Surface Parameters as a Function of the Meibomian Gland Dropout Rate","volume":"37","author":"Mihaltz","year":"2018","journal-title":"Cornea"},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Rolando, M., and Valente, C. (2007). Establishing the tolerability and performance of tamarind seed polysaccharide (TSP) in treating dry eye syndrome: Results of a clinical study. BMC Ophthalmol., 7.","DOI":"10.1186\/1471-2415-7-5"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.jtos.2016.08.004","article-title":"A Two-Week, Randomized, Double-masked Study to Evaluate Safety and Efficacy of Lubricin (150 mug\/mL) Eye Drops Versus Sodium Hyaluronate (HA) 0.18% Eye Drops (Vismed(R)) in Patients with Moderate Dry Eye Disease","volume":"15","author":"Lambiase","year":"2017","journal-title":"Ocul. Surf."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1016\/j.ophtha.2012.12.022","article-title":"A randomized, multicenter phase 3 study comparing 2% rebamipide (OPC-12759) with 0.1% sodium hyaluronate in the treatment of dry eye","volume":"120","author":"Kinoshita","year":"2013","journal-title":"Ophthalmology"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"9013","DOI":"10.1038\/s41598-017-08534-5","article-title":"Sodium Hyaluronate in the Treatment of Dry Eye Syndrome: A Systematic Review and Meta-Analysis","volume":"7","author":"Ang","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1185\/03007995.2015.1125871","article-title":"Sodium hyaluronate\u2019s effect on xerophthalmia: A meta-analysis of randomized controlled trials","volume":"32","author":"Kong","year":"2016","journal-title":"Curr. Med. Res. Opin."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"2","DOI":"10.4082\/kjfm.2017.38.1.2","article-title":"Efficacy of Carboxymethylcellulose and Hyaluronate in Dry Eye Disease: A Systematic Review and Meta-Analysis","volume":"38","author":"Song","year":"2017","journal-title":"Korean J. Fam. Med."},{"key":"ref_24","unstructured":"Higgins, J., and Thomas, J. (2020, May 05). Cochrane Handbook for Systematic Reviews of Interventions. Available online: https:\/\/training.cochrane.org\/handbook\/current."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"546","DOI":"10.5301\/ejo.5000830","article-title":"Efficacy and safety of a cationic emulsion in the treatment of moderate to severe dry eye disease: A randomized controlled study","volume":"26","author":"Robert","year":"2016","journal-title":"Eur. J. Ophthalmol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1097\/ICL.0000000000000284","article-title":"Safety and Efficacy of an Artificial Tear Containing 0.3% Hyaluronic Acid in the Management of Moderate-to-Severe Dry Eye Disease","volume":"43","year":"2017","journal-title":"Eye Contact Lens"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.clae.2017.07.007","article-title":"Can the optimum artificial tear treatment for dry eye disease be predicted from presenting signs and symptoms?","volume":"41","author":"Essa","year":"2018","journal-title":"Contact Lens Anterior Eye"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.2147\/OPTH.S161578","article-title":"Comparative study of 0.1% hyaluronic acid versus 0.5% carboxymethylcellulose in patients with dry eye associated with moderate keratitis or keratoconjunctivitis","volume":"12","author":"Gross","year":"2018","journal-title":"Clin. Ophthalmol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"751","DOI":"10.5301\/ejo.5000117","article-title":"Randomized, phase III study comparing osmoprotective carboxymethylcellulose with sodium hyaluronate in dry eye disease","volume":"22","author":"Baudouin","year":"2012","journal-title":"Eur. J. Ophthalmol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1007\/s00417-004-1040-6","article-title":"Efficacy and safety of 0.18% sodium hyaluronate in patients with moderate dry eye syndrome and superficial keratitis","volume":"243","author":"Brignole","year":"2005","journal-title":"Graefe\u2019s Arch. Clin. Exp. Ophthalmol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1136\/bjo.83.10.1121","article-title":"Double blind, randomised, placebo controlled, crossover, multicentre study to determine the efficacy of a 0.1% (w\/v) sodium hyaluronate solution (Fermavisc) in the treatment of dry eye syndrome","volume":"83","author":"Condon","year":"1999","journal-title":"Br. J. Ophthalmol."},{"key":"ref_32","first-page":"174","article-title":"A comparative study of two preservative-free tear substitutes in the management of severe dry eye","volume":"23","author":"Laflamme","year":"1988","journal-title":"Can. J. Ophthalmol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1097\/ICO.0b013e3181e9adcc","article-title":"Efficacy of sodium hyaluronate and carboxymethylcellulose in treating mild to moderate dry eye disease","volume":"30","author":"Lee","year":"2011","journal-title":"Cornea"},{"key":"ref_34","unstructured":"NCT (2020, September 11). Study to Compare the Efficacy and Safety of Two Non-Preserved Artificial Tears for the Treatment of Dry Eye Signs and Symptoms, Available online: https:\/\/clinicaltrials.gov\/show\/NCT00938704."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1001\/archopht.1988.01060130530029","article-title":"Sodium hyaluronate and polyvinyl alcohol artificial tear preparations. A comparison in patients with keratoconjunctivitis sicca","volume":"106","author":"Nelson","year":"1988","journal-title":"Arch. Ophthalmol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.jtos.2017.05.001","article-title":"TFOS DEWS II Diagnostic Methodology report","volume":"15","author":"Wolffsohn","year":"2017","journal-title":"Ocul. Surf."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1097\/00006324-199302000-00011","article-title":"Schirmer test. I. A review","volume":"70","author":"Cho","year":"1993","journal-title":"Optom. Vis. Sci."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.clae.2010.01.003","article-title":"Tear osmolarity measurement using the TearLab\u2122 Osmolarity System in the assessment of dry eye treatment effectiveness","volume":"33","author":"Benelli","year":"2010","journal-title":"Contact Lens Anterior Eye"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1038\/eye.2000.244","article-title":"Improvement of the ocular surface using hypotonic 0.4% hyaluronic acid drops in keratoconjunctivitis sicca","volume":"14","author":"Iester","year":"2000","journal-title":"Eye (Lond.)"},{"key":"ref_40","doi-asserted-by":"crossref","unstructured":"(2007). Methodologies to diagnose and monitor dry eye disease: Report of the Diagnostic Methodology Subcommittee of the International Dry Eye WorkShop (2007). Ocul. Surf., 5, 108\u2013152.","DOI":"10.1016\/S1542-0124(12)70083-6"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"6125","DOI":"10.1167\/iovs.10-5390","article-title":"An objective approach to dry eye disease severity","volume":"51","author":"Sullivan","year":"2010","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S1542-0124(12)70040-X","article-title":"Patient-reported symptoms in dry dye disease","volume":"4","author":"Nichols","year":"2006","journal-title":"Ocul. Surf."}],"container-title":["International Journal of Environmental Research and Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1660-4601\/18\/5\/2383\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T05:30:55Z","timestamp":1760160655000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1660-4601\/18\/5\/2383"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,1]]},"references-count":42,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2021,3]]}},"alternative-id":["ijerph18052383"],"URL":"https:\/\/doi.org\/10.3390\/ijerph18052383","relation":{},"ISSN":["1660-4601"],"issn-type":[{"value":"1660-4601","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,1]]}}}